Breast Lesion Localization Devices Market Report 2024 (Global Edition)

Global Breast Lesion Localization Devices Market Report 2024 Market Size Split by Technique (Wire Localization, Non-Wire Localization, Radar Reflector Localization, Magnetic seed Localization, RFID Ta...

Breast Lesion Localization Devices Market Report Description

We have various report editions of Breast Lesion Localization Devices Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Breast Lesion Localization Devices Market Insights Video

Competitive Landscape of the Breast Lesion Localization Devices market

Key players are focused on the development and launch of novel detection devices for breast cancers. Established players within the industry are targeting specific female groups and going after strategic mergers and acquisitions to strengthen their position in the cancer devices market.

Breast Lesion Localization Devices Industry News

For instance, Siemens Healthineers unveiled Mammovista B.smart on March 3, 2021, a new software program streamlining the entire breast imaging reading process. Additionally, growing startup company investments in cancer treatment are boosting market revenue.

Source-www.itnonline.com/content/siemens-healthineers-introduces-mammomat-revelation-mammography-system-improved-biopsy

Top Companies Market Share in Breast Lesion Localization Devices Industry: (In no particular order of Rank)

• Merit Medical Systems
• BD
• ARGON MEDICAL
• Hologic Inc.
• Endomagnetics Ltd.
• MatekMedikal
• Sirius Medical Systems B.V.
• Izi Medical Products LLC
• Molli Surgical Inc
• Elucent Medical
• Intramedical Imaging
• Isoaid
• Vigeosrl
• Medax Medical Devices
• MDL SRL
• BPB Medica
• Sterylab S.R.L. 
• Tsunami Medical Srl
• LauraneR Medical LLC
• Biomedical Srl
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

In terms of revenue, the North America Breast Lesion Localization Devices market share was 40% of the total market

According to Cognitive Market Research, North America dominated the market in 2023 and accounted for around 40% of the global revenue. The region witnessed substantial investments in research and development, leading to the introduction of cutting-edge devices for breast lesion localization. Additionally, a proactive approach to breast cancer screening and a high prevalence of breast cancer contribute to the market’s growth.

European nations prioritize personalized medicine, contributing to the integration of precision-focused breast lesion localization devices into clinical practice. The competitive landscape is dynamic, with key players focusing on expanding their market presence and catering to the evolving needs of healthcare providers.

The current report Scope analyzes Breast Lesion Localization Devices Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Breast Lesion Localization Devices

According to Cognitive Market Research, the global Breast Lesion Localization Devices market size was estimated at USD 315.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 126.08 Million in 2023 and will grow at a compound annual growth rate (CAGR) of 3.2% from 2023 to 2030, the market in North America has seen significant growth. Technological innovations, stringent regulatory frameworks, and a culture of early detection contribute to the adoption of state-of-the-art localization devices. The dominant segment in North America is Wire Localization, which involves the insertion of a thin wire into the breast tissue to guide surgeons to the exact location of the lesion during surgical procedures, ensuring accurate excision. This method is particularly employed when lesions are small, non-palpable, or challenging to locate visually.

In conclusion, North America remains a key driver of innovation and growth in the Breast Lesion Localization Devices market, contributing significantly to the global efforts in combating and managing breast cancer.

• According to Cognitive Market Research, the USA had a major share in the Breast Lesion Localization Devices market, with a market size of USD 99.48 million in 2023, which is projected to grow at a CAGR of 3.0% during the forecast period. The Breast Lesion Localization Devices market thrives amidst a well-established healthcare ecosystem and a proactive approach to breast cancer management. The country, with its advanced medical infrastructure and emphasis on 
• The Canada Breast Lesion Localization Devices market had a market share of USD 15.13 Million in 2023 and is projected to grow at a CAGR of 4.0% during the forecast period. The breast Lesion Localization Devices market is characterized by a robust healthcare system and a population keen on comprehensive breast health. 
• The Mexico Breast Lesion Localization Devices market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 11.47 Million in 2023.

 

Europe Breast Lesion Localization Devices

According to Cognitive Market Research, the global Breast Lesion Localization Devices market size was estimated at USD 315.2 Million, out of which Europe held the major market of more than 30% of the global revenue with market size of USD 94.56 Million in 2023 and will grow at a compound annual growth rate (CAGR) of 3.5% from 2023 to 2030, The region’s regulatory environment supports innovation, leading to the development and adoption of cutting- edge localization technologies. European nations prioritize comprehensive breast cancer screening programs, fostering the demand for advanced localization devices in diagnostic and therapeutic procedures. The dominant segment in Europe is Non-wire localization; this innovative category includes various localization techniques such as radiofrequency identification (RFID), magnetic seeds, and radiofrequency reflectors. Unlike wire-based methods, Non-Wire Localization offers several advantages, including enhanced patient comfort, reduced procedural complexity, and increased precision in lesion localization. 

In conclusion, Europe’s role in driving advancements and shaping the landscape of the Breast Lesion Localization Devices market is pivotal, reinforcing its position as a leader in healthcare innovation.

• According to Cognitive Market Research, the German breast Lesion Localization Devices market size was valued at USD 18.72 million in 2023 and is projected to grow at a CAGR of 3.7% during the forecast period. The emphasis on precision diagnostics and early intervention aligns with the nation’s proactive healthcare approach.
• The United Kingdom Breast Lesion Localization Devices market had a market share of USD 15.89 million in 2023 and is projected to grow at a CAGR of 4.3% during the forecast period. UK play pivotal roles in driving advancements in Breast Lesion Localization technologies, contributing to improved breast cancer outcomes regionally and globally.
• The France Breast Lesion Localization Devices market is projected to witness growth at a CAGR of 2.7% during the forecast period, with a market size of USD 8.70 million in 2023.
• The Italy Breast Lesion Localization Devices market is projected to witness growth at a CAGR of 2.9% during the forecast period, with a market size of USD 8.13 million in 2023.
• The Russia Breast Lesion Localization Devices market is projected to witness growth at a CAGR of 2.5% during the forecast period, with a market size of USD 14.66 million in 2023.
• The Spain Breast Lesion Localization Devices market is projected to witness growth at a CAGR of 2.6% during the forecast period, with a market size of USD 7.75 million in 2023.
• The Portugal Breast Lesion Localization Devices market is projected to witness growth at a CAGR of 3.3% during the forecast period, with a market size of USD 1.99 million in 2023.
• The Luxembourg Breast Lesion Localization Devices market is projected to witness growth at a CAGR of 3.6% during the forecast period, with a market size of USD 2.93 million in 2023.
• The Greece Breast Lesion Localization Devices market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD 1.13 million in 2023.
• The Rest of the Europe Breast Lesion Localization Devices market is projected to witness growth at a CAGR of 2.2% during the forecast period, with a market size of USD 1.13 million in 2023.

 

Asia Pacific Breast Lesion Localization Devices

According to Cognitive Market Research, the global Breast Lesion Localization Devices market size was estimated at USD 315.2 Million, out of which Asia Pacific held the major market of more than 23% of the global revenue with market size of USD 72.50 million in 2023 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2023 to 2030, As economies in the region grow, there is an expanding focus on advanced medical technologies, fostering the adoption of Breast Lesion Localization Devices for precise diagnostic and therapeutic interventions. The market benefits from a diverse set of regulatory environments, with some countries actively investing in healthcare infrastructure and others undergoing rapid technological advancements. The dominant segment is The market’s expansion is further fueled by ongoing technological advancements, increased awareness of breast cancer screening, and a growing preference for minimally invasive techniques in oncological procedures, positioning Non-Wire Localization as a promising and evolving field within breast cancer diagnostics and treatment. 

In conclusion, The evolving healthcare ecosystems in countries across the region position Asia Pacific as a key contributor to the advancement of Breast Lesion Localization technologies.

• According to Cognitive Market Research, the size of the China Breast Lesion Localization Devices market was valued at USD 32.62 million in 2023 and is projected to grow at a CAGR of 6.5% during the forecast period. The country’s large population and rising breast cancer prevalence contribute to a significant demand for effective diagnostic and therapeutic solutions. 
• The Japan Breast Lesion Localization Devices market had a market share of USD 10.00 million in 2023 and is projected to grow at a CAGR of 5.5% during the forecast period. The Breast Lesion Localization Devices market thrives within a well-
• established healthcare system is known for technological prowess.
• The India Breast Lesion Localization Devices market is projected to witness growth at a CAGR of 8.8% during the forecast period, with a market size of USD 8.70 million in 2023.
• The South Korea Breast Lesion Localization Devices market is projected to witness growth at a CAGR of 6.1% during the forecast period, with a market size of USD 7.25 million in 2023.
• The Australia Breast Lesion Localization Devices market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 3.77 million in 2023.
• The Southeast Asia Breast Lesion Localization Devices market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 5.00 million in 2023.
• The Rest of Asia Pacific Breast Lesion Localization Devices market is projected to witness growth at a CAGR of 6.8% during the forecast period with a market size of USD 5.15 million in 2023.

 

South America Breast Lesion Localization Devices

According to Cognitive Market Research, the global Breast Lesion Localization Devices market size was estimated at USD 315.2 Million, out of which Latin America held the major market of more than 5% of the global revenue with market size of USD 15.76 million in 2023 and will grow at a compound annual growth rate (CAGR) of 4.4% from 2023 to 2030, The region is characterized by a growing awareness of breast health, improving healthcare infrastructure, and an increasing prevalence of breast cancer. Latin America’s diverse regulatory environment influences the adoption of Breast Lesion Localization Devices, with some countries witnessing rapid technological integration. The dominant segment in Latin America is Breast Biospy, it plays a crucial role in the accurate diagnosis and subsequent treatment planning for breast abnormalities detected through imaging studies. Breast biopsies can be performed using various localization techniques, including wire-guided, magnetic, or ultrasound-guided methods.

In conclusion, Latin America presents a promising growth landscape for the Breast Lesion Localization Devices market. The region’s commitment to improving healthcare outcomes, coupled with evolving healthcare systems, positions it as a key contributor to global advancements in breast cancer diagnostics and treatment.

• According to Cognitive Market Research, the Brazil Breast Lesion Localization Devices market size was valued at USD 6.75 million in 2023 and is projected to grow at a CAGR of 5.0% during the forecast period. Brazil’s dynamic healthcare landscape and regulatory developments create opportunities for global and local manufacturers to contribute to the evolving market.
• The Argentina Breast Lesion Localization Devices market had a market share of USD 2.65 million in 2023 and is projected to grow at a CAGR of 5.3% during the forecast period. Argentina plays a crucial role in advancing Breast Lesion Localization Devices within the South American market.
• The Colombia Breast Lesion Localization Devices market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 1.40 million in 2023.
• The Peru Breast Lesion Localization Devices market is projected to witness growth at a CAGR of 4.6% during the forecast period, with a market size of USD 1.29 million in 2023.
• The Chile Breast Lesion Localization Devices market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 1.13 million in 2023.
• The Rest of the Latin America Breast Lesion Localization Devices market is projected to witness growth at a CAGR of 3.5% during the forecast period, with a market size of USD 2.54 million in 2023.

 

Middle East and Africa Breast Lesion Localization Devices

According to Cognitive Market Research, the global Breast Lesion Localization Devices market size was estimated at USD 315.2 Million, out of which Middle East and Africa held the major market of more than 2.00% of the global revenue with market size of USD 14.30 million in 2023 and will grow at a compound annual growth rate (CAGR) of 5.9% from 2023 to 2030, The market in MEA is characterized by diverse healthcare systems, with some countries actively investing in advanced medical technologies. Breast cancer awareness initiatives are gaining momentum, contributing to the demand for effective diagnostic and therapeutic solutions. The dominant segment in MEA is breast lumpectomy, it involves the removal of a localized tumor or lesion while preserving the surrounding healthy breast tissue. Localization devices in this segment assist surgeons in precisely identifying and excising the targeted lesion during the lumpectomy procedure.

In conclusion, MEA represents a region with growing potential for the Breast Lesion Localization Devices market. Its commitment to improving healthcare outcomes, coupled with ongoing advancements, positions it as a significant contributor to global efforts in enhancing breast cancer diagnostics and treatment.

• According to Cognitive Market Research, the GCC Countries' Breast Lesion Localization Devices market size was valued at USD 2.70 million in 2023 and is projected to grow at a CAGR of 5.5% during the forecast period. The region's commitment to providing state-of-the-art medical services is reflected in the adoption of advanced Breast Lesion Localization Devices.
• The South Africa Breast Lesion Localization Devices market had a market share of USD 1.00 million in 2023 and is projected to grow at a CAGR of 5.7% during the forecast period. The breast Lesion Localization Devices market is influenced by the nation’s commitment to addressing healthcare challenges. 
• The Egyptian Breast Lesion Localization Devices market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 0.66 million in 2023.
• The Turkey Breast Lesion Localization Devices market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 0.54 million in 2023.
• The Nigeria Breast Lesion Localization Devices market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD 0.66 million in 2023.
• The Rest of MEA Breast Lesion Localization Devices market is projected to witness growth at a CAGR of 3.7% during the forecast period with a market size of USD 0.77 million in 2023.

 

Breast Lesion Localization Devices Market Analysis

Breast Lesion Localization Devices Market Technique Segment Analysis

According to Cognitive Market Research, wire localization held the major market share over the forecast period. The Wire Localization segment within the Breast Lesion Localization Devices market plays a crucial role in pre-surgical planning for breast cancer patients. These devices are utilized to precisely locate and mark abnormal breast lesions identified through imaging techniques such as mammography or ultrasound.

Non-wire localization in the breast lesion localization devices market represents a cutting-edge approach to guiding breast cancer surgery without the use of traditional wires. This innovative category includes various localization techniques such as radiofrequency identification (RFID), magnetic seeds, and radiofrequency reflectors.

• Wire Localization
• Non-Wire Localization
• Radar Reflector Localization
• Magnetic seed Localization
• RFID Tag Localization
• Radioisotope Localization 

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Breast Lesion Localization Devices Industry. Request a Free Sample PDF!

Breast Lesion Localization Devices Market Application Segment Analysis

According to Cognitive Market Research, breast biopsy held the major market share over the forecast period. The Breast Biopsy segment is witnessing advancements in technology, such as vacuum-assisted and core needle biopsy systems, which offer improved accuracy and reduced invasiveness. The increasing incidence of breast cancer, coupled with the growing emphasis on early and accurate diagnosis, contributes to the sustained growth of the Breast Biopsy segment, making it a pivotal player in the overall Breast Lesion Localization Devices market.

The breast lumpectomy segment involves the removal of a localized tumor or lesion while preserving the surrounding healthy breast tissue. Localization devices in this segment assist surgeons in precisely identifying and excising the targeted lesion during the lumpectomy procedure.

• Breast Biopsy
• Breast Lumpectomy 

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Breast Lesion Localization Devices End User Segment Analysis

According to Cognitive Market Research, hospitals maintain dedicated blood banks equipped with advanced technologies for efficient blood testing, storage, and distribution. They collaborate with blood donation drives, ensuring a steady supply of safe blood for various medical procedures, emergency situations, and surgeries.

The specialty clinics segment is gaining prominence due to its patient-centric approach, offering focused care for individuals seeking breast health services. The growing demand for specialized and streamlined breast care contributes to the expansion of the Breast Lesion Localization Devices market, with specialty clinics serving as essential hubs for delivering tailored and efficient breast cancer care.

• Hospitals
• Ambulatory Surgical Centres
• Specialty Clinics 

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion